Copyright
©The Author(s) 2022.
World J Diabetes. Apr 15, 2022; 13(4): 376-386
Published online Apr 15, 2022. doi: 10.4239/wjd.v13.i4.376
Published online Apr 15, 2022. doi: 10.4239/wjd.v13.i4.376
Index | Within the first 6 mo | After 6 mo | ||||||
Died (n = 41) | Survived (n = 527) | χ2/Z | P | Died (n = 113) | Survived (n = 395) | χ2/Z | P | |
Demographic characteristics | ||||||||
Age, yr, M (P25, P75) | 66.0 (57.0, 75.0) | 58.0 (51.0, 66.0) | -4.003 | < 0.001 | 61.0 (55.0, 67.0) | 58.0 (50.0, 64.0) | -3.357 | 0.001 |
Gender, male, n (%) | 22 (53.7) | 322 (61.1) | 0.882 | 0.348 | 65 (57.5) | 244 (61.8) | 0.666 | 0.414 |
Abdominal surgery history, n (%) | 3 (7.3) | 64 (12.1) | 0.852 | 0.356 | 13 (11.5) | 47 (11.9) | 0.013 | 0.909 |
Co-morbidities, n (%) | ||||||||
Cerebrovascular disease, n (%) | 12 (29.3) | 112 (21.3) | 1.432 | 0.231 | 28 (24.8) | 82 (20.8) | 0.837 | 0.360 |
Hypertension, n (%) | 40 (97.6) | 512 (97.2) | 0.000 | 1.000 | 110 (97.3) | 384 (97.2) | 0.006 | 0.941 |
NYHA-FC | - | - | 11.647 | 0.009 | - | - | 9.265 | 0.026 |
0 | 14 (34.1) | 254 (48.2) | - | - | 46 (40.7) | 196 (49.6) | - | - |
I | 4 (9.76) | 97 (18.4) | - | - | 16 (16.2) | 79 (20.0) | - | - |
II | 4 (9.76) | 55 (10.4) | - | - | 14 (12.4) | 39 (9.9) | - | - |
III-IV | 19 (46.3) | 121 (23.0) | - | - | 37 (32.7) | 118 (23.2) | ||
Laboratory test | ||||||||
WBC (109/L) | 7.24 (6.11, 9.13) | 7.26 (5.70, 8.60) | -0.674 | 0.501 | 6.82 (5.51, 7.75) | 7.40 (5.77, 8.71) | -1.891 | 0.059 |
Alb (g/L) | 31.20 (28.00, 33.95) | 32.39 (28.80, 36.00) | -1.436 | 0.151 | 32.38 (29.00, 35.50) | 32.30 (28.60, 36.00) | -0.202 | 0.840 |
Hb (g/L) | 86.0 (74.5, 98.0) | 86.0 (74.0, 97.0) | -0.214 | 0.831 | 85.0 (74.0, 95.0) | 86.0 (74.0, 97.0) | -0.677 | 0.498 |
K (mmol/L) | 4.57 (3.91, 5.11) | 4.57 (4.00, 5.09) | -0.195 | 0.845 | 4.50 (3.95, 4.92) | 4.61 (4.01, 5.13) | -1.442 | 0.149 |
Na (mmol/L) | 140.00 (136.60, 142.50) | 140.03 (138.00, 142.30) | -0.909 | 0.363 | 140.10 (137.95, 142.85) | 140.10 (138.00, 142.30) | -0.364 | 0.176 |
Ca (mmol/L) | 1.95 (1.77, 2.13) | 1.97 (1.84, 2.11) | -0.875 | 0.382 | 1.99 (1.88, 2.11) | 1.96 (1.81, 2.11) | -1.348 | 0.178 |
P (mmol/L) | 2.00 (1.60, 2.41) | 1.87 (1.48, 2.16) | -1.145 | 0.252 | 1.71 (1.42, 2.05) | 1.88 (1.53, 2.18) | -3.242 | 0.001 |
Boold glucose (mmol/L) | 6.91 (5.60, 9.96) | 6.16 (4.83, 7.70) | -2.555 | 0.011 | 6.30 (4.87, 8.52) | 6.16 (4.83, 7.56) | -0.547 | 0.584 |
Scr (μmol/L) | 646.80 (484.45, 806.85) | 710.00 (562.00, 876.10) | -1.855 | 0.064 | 642.00 (532.25, 840.25) | 723.05 (578.80, 887.80) | -2.626 | 0.009 |
Causes | Number of mortalities within the first 6 mo, n (%) | Number of the mortalities after 6 mo, n (%) |
Infectious diseases | 4 (9.76) | 16 (14.16) |
Cardiovascular events | 11 (26.83) | 36 (31.86) |
Cerebrovascular disorder | 3 (7.32) | 10 (8.85) |
Respiratory failure | 8 (19.51) | 14 (12.39) |
Malignancy | 3 (7.32) | 3 (2.66) |
Multiple organ dysfunction | 3 (7.32) | 2 (1.77) |
Unknown | 9 (21.95) | 32 (28.32) |
Total | 41 (100.00) | 113 (100.00) |
- Citation: Cheng SY, Yang LM, Sun ZS, Zhang XX, Zhu XY, Meng LF, Guo SZ, Zhuang XH, Luo P, Cui WP. Risk factors for mortality within 6 mo in patients with diabetes undergoing urgent-start peritoneal dialysis: A multicenter retrospective cohort study. World J Diabetes 2022; 13(4): 376-386
- URL: https://www.wjgnet.com/1948-9358/full/v13/i4/376.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i4.376